.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Boehringer Ingelheim
Deloitte
Accenture
Express Scripts
Medtronic
Johnson and Johnson
AstraZeneca
Chubb
Chinese Patent Office

Generated: June 27, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075811

« Back to Dashboard
NDA 075811 describes MESNA, which is a drug marketed by Fresenius Kabi Usa, Sagent Pharms, West-ward Pharms Int, Mylan Labs Ltd, Teva Pharms Usa, and Mylan Institutional, and is included in six NDAs. It is available from five suppliers. Additional details are available on the MESNA profile page.

The generic ingredient in MESNA is mesna. There are ten drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the mesna profile page.

Summary for NDA: 075811

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Pharmacology for NDA: 075811

Suppliers and Packaging for NDA: 075811

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MESNA
mesna
INJECTABLE;INTRAVENOUS 075811 ANDA Fresenius Kabi USA, LLC 63323-733 63323-733-10 10 VIAL, MULTI-DOSE in 1 TRAY (63323-733-10) > 10 mL in 1 VIAL, MULTI-DOSE
MESNA
mesna
INJECTABLE;INTRAVENOUS 075811 ANDA Fresenius Kabi USA, LLC 63323-733 63323-733-11 1 VIAL, MULTI-DOSE in 1 BOX (63323-733-11) > 10 mL in 1 VIAL, MULTI-DOSE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INTRAVENOUSStrength100MG/ML
Approval Date:Apr 26, 2001TE:APRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Cantor Fitzgerald
Argus Health
Boehringer Ingelheim
Teva
Fuji
Merck
Moodys
Colorcon
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot